Dr. Alex Chehrazi-Raffle

Claim this profile
Studies Skin Cancer
Studies Renal Cell Carcinoma
1 reported clinical trial
3 drugs studied

Clinical Trials Alex Chehrazi-Raffle is currently running

Image of trial facility.

CBM588 + Nivolumab + Ipilimumab

for Advanced Kidney Cancer

This phase I trial tests the safety, side effects, best dose, and effectiveness of CBM588 in combination with nivolumab and ipilimumab in treating patients with kidney cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced). CBM588 is a live biotherapeutic that may help improve the effects of immunotherapy. Nivolumab and ipilimumab are monoclonal antibodies that may interfere with the ability of tumor cells to grow and spread by enhancing the ability of the body's immune cells to attack tumor cells. CBM588 in combination with nivolumab and ipilimumab may be safe, tolerable, and/or effective in treating patients with advanced stage kidney cancer.
Recruiting1 award Phase 17 criteria

More about Alex Chehrazi-Raffle

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Alex Chehrazi-Raffle has experience with
  • CBM588
  • Ipilimumab
  • Nivolumab
Breakdown of trials Alex Chehrazi-Raffle has run
Skin Cancer
Renal Cell Carcinoma
Kidney Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alex Chehrazi-Raffle specialize in?
Alex Chehrazi-Raffle focuses on Skin Cancer and Renal Cell Carcinoma. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Alex Chehrazi-Raffle currently recruiting for clinical trials?
Yes, Alex Chehrazi-Raffle is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Alex Chehrazi-Raffle has studied deeply?
Yes, Alex Chehrazi-Raffle has studied treatments such as CBM588, Ipilimumab, Nivolumab.
What is the best way to schedule an appointment with Alex Chehrazi-Raffle?
Apply for one of the trials that Alex Chehrazi-Raffle is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top